Cytek Biosciences's market cap is currently $669.82M. The company's EPS TTM is $-0.077; its P/E ratio is ―; Cytek Biosciences is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 193.01M	$ 164.04M	$ 127.95M	$ 92.84M	$ 57.88M
Gross Profit	$ 109.43M	$ 100.97M	$ 79.14M	$ 51.71M	$ 28.67M
Operating Income	$ -27.84M	$ -1.83M	$ 6.45M	$ 13.66M	$ 3.73M
EBITDA	$ -4.41M	$ 9.54M	$ 10.40M	$ 15.37M	$ -15.98M
Net Income	$ -12.15M	$ 2.58M	$ 4.42M	$ 19.41M	$ -16.83M
Balance Sheet
Cash & Short-Term Investments	$ 262.41M	$ 341.15M	$ 364.62M	$ 165.23M	$ 30.12M
Total Assets	$ 494.46M	$ 519.48M	$ 463.70M	$ 219.98M	$ 70.36M
Total Debt	$ 14.14M	$ 18.09M	$ 0.00	$ 2.77M	$ 0.00
Net Debt	$ -153.16M	$ -278.51M	$ -364.62M	$ -162.46M	$ -30.12M
Total Liabilities	$ 101.39M	$ 93.93M	$ 56.90M	$ 236.01M	$ 112.06M
Stockholders' Equity	$ 393.06M	$ 425.30M	$ 406.46M	$ -16.03M	$ -41.70M
Cash Flow
Free Cash Flow	$ 454.00K	$ -22.10M	$ 266.00K	$ 13.61M	$ -14.72M
Operating Cash Flow	$ 5.28M	$ -12.23M	$ 4.63M	$ 15.16M	$ -13.75M
Investing Cash Flow	$ -93.89M	$ -55.91M	$ -20.99M	$ -1.55M	$ -973.00K
Financing Cash Flow	$ -41.81M	$ 5.51M	$ 213.56M	$ 122.61M	$ 93.00K

Currency in USD

Cytek Biosciences Earnings and Revenue History

Income Statement >

Cytek Biosciences Debt to Assets

Balance Sheet >

Cytek Biosciences Cash Flow

Cash Flow >

Cytek Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing